 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
3-13-2020
Insider Buy |
Kazuko Matsuda
Chief Medical Officer |
$3.62
CAGR »
|
$7,240.00
2,000 shares |
3-12-2020
Insider Buy |
Yuichi Iwaki
President and CEO |
$3.10
CAGR »
|
$62,000.00
20,000 shares |
8-21-2017
Insider Buy |
Yoshio Ishizaka
Director |
$5.17
CAGR »
|
$25,850.00
5,000 shares |
5-15-2017
Insider Buy |
Yutaka Kobayashi
Director |
$5.60
CAGR »
|
$5,600.00
1,000 shares |
5-12-2017
Insider Buy |
Yutaka Kobayashi
Director |
$5.62
CAGR »
|
$134,880.00
24,000 shares |
9-15-2016
Insider Buy |
Yutaka Kobayashi
Director |
$6.44
CAGR »
|
$75,992.00
11,800 shares |
9-9-2016
Insider Buy |
Yutaka Kobayashi
Director |
$6.67
CAGR »
|
$66,700.00
10,000 shares |
12-10-2014
Insider Buy |
Yutaka Kobayashi
Director |
$3.54
CAGR »
|
$42,480.00
12,000 shares |
11-26-2014
Insider Buy |
Yutaka Kobayashi
Director |
$3.07
CAGR »
|
$30,700.00
10,000 shares |
11-20-2014
Insider Buy |
Yutaka Kobayashi
Director |
$3.19
CAGR »
|
$41,470.00
13,000 shares |
11-19-2014
Insider Buy |
Yoshio Ishizaka
Director |
$2.86
CAGR »
|
$14,300.00
5,000 shares |
9-11-2014
Insider Buy |
Yutaka Kobayashi
Director |
$2.95
CAGR »
|
$29,500.00
10,000 shares |
9-3-2014
Insider Buy |
Yutaka Kobayashi
Director |
$2.66
CAGR »
|
$39,849.00
15,000 shares |
11-18-2013
Insider Buy |
Tatsuo Izumi
Director |
$2.21
CAGR »
|
$2,812.40
1,270 shares |
5-13-2013
Insider Buy |
Tatsuo Izumi
Director |
$3.15
CAGR »
|
$499,999.50
158,730 shares |
5-31-2012
Insider Buy |
Tatsuo Izumi
Director |
$1.81
CAGR »
|
$9,412.00
5,200 shares |
5-29-2012
Insider Buy |
Tatsuo Izumi
Director |
$1.95
CAGR »
|
$71,268.00
36,600 shares |
5-29-2012
Insider Buy |
David D. O'toole
Director |
$1.78
CAGR »
|
$8,900.00
5,000 shares |
Also See: Institutional Holders of MNOV
Also See: SEC filings
Below we present the annualized performance delivered by MNOV stock since 3-13-2020 (the date of the most recent
insider purchase). The performance of the investment from the time MNOV insider buying occurred is the ultimate
test of whether insiders were right about MNOV being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/16/2020 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$3.93 |
|
| End price/share: |
$1.31 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-66.67% |
|
| Average Annual Total Return: |
-23.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,333.45 |
|
| Years: |
4.12 |
|
MNOV Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent MNOV insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding MNOV
|
|
Free MNOV Email Alerts:
